Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
Open Access
- 16 November 2013
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1), 549
- https://doi.org/10.1186/1471-2407-13-549
Abstract
Resistance to platinum-based chemotherapy remains a major impediment in the treatment of serous epithelial ovarian cancer. The objective of this study was to use gene expression profiling to delineate major deregulated pathways and biomarkers associated with the development of intrinsic chemotherapy resistance upon exposure to standard first-line therapy for ovarian cancer.Keywords
This publication has 62 references indexed in Scilit:
- Assessing the range of kinase autoinhibition mechanisms in the insulin receptor familyBiochemical Journal, 2012
- SCOREM: statistical consolidation of redundant expression measuresNucleic Acids Research, 2011
- The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinomaGynecologic Oncology, 2011
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanomaCancer Causes & Control, 2011
- Targeted Therapies in Epithelial Ovarian CancerJournal of Oncology, 2010
- Treatment for Recurrent Ovarian Cancer—At First RelapseJournal of Oncology, 2009
- arrayQualityMetrics—a bioconductor package for quality assessment of microarray dataBioinformatics, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Wnt Signaling in the Niche Enforces Hematopoietic Stem Cell Quiescence and Is Necessary to Preserve Self-Renewal In VivoCell Stem Cell, 2008